These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23098242)

  • 1. Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
    Grant DJ; Hoyo C; Oliver SD; Gerber L; Shuler K; Calloway E; Gaines AR; McPhail M; Livingston JN; Richardson RM; Schildkraut JM; Freedland SJ
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):3-9. PubMed ID: 23098242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
    Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
    Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
    Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
    Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.
    Schulze JJ; Lorentzon M; Ohlsson C; Lundmark J; Roh HK; Rane A; Ekström L
    Pharmacogenet Genomics; 2008 Jun; 18(6):477-85. PubMed ID: 18496127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
    Park JY; Tanner JP; Sellers TA; Huang Y; Stevens CK; Dossett N; Shankar RA; Zachariah B; Heysek R; Pow-Sang J
    Urology; 2007 Aug; 70(2):374-9. PubMed ID: 17826523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
    Ménard V; Eap O; Harvey M; Guillemette C; Lévesque E
    Hum Mutat; 2009 Sep; 30(9):1310-9. PubMed ID: 19572376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer.
    MacLeod SL; Nowell S; Plaxco J; Lang NP
    Ann Surg Oncol; 2000 Dec; 7(10):777-82. PubMed ID: 11129427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
    Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y).
    Lampe JW; Bigler J; Bush AC; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):329-33. PubMed ID: 10750673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.
    Grant DJ; Chen Z; Howard LE; Wiggins E; De Hoedt A; Vidal AC; Carney ST; Squires J; Magyar CE; Huang J; Freedland SJ
    BMC Cancer; 2017 Jul; 17(1):463. PubMed ID: 28673330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.
    Barbier O; Bélanger A
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):259-70. PubMed ID: 18471784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.
    Cai L; Huang W; Chou KC
    Protein Pept Lett; 2012 Jan; 19(1):62-9. PubMed ID: 21919858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation.
    Chouinard S; Pelletier G; Bélanger A; Barbier O
    Endocrinology; 2006 Nov; 147(11):5431-42. PubMed ID: 16887906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
    Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis.
    Zhong X; Feng J; Xiao Y; Wang P; Fan Q; Wu R; Hu W; Huang C
    Oncotarget; 2017 Aug; 8(32):52837-52845. PubMed ID: 28881775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.
    Chouinard S; Barbier O; Bélanger A
    J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.